✦ LIBER ✦

HLA antigens and adverse drug reactions to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis

✍ Scribed by S. Rantapää Dahlqvist; H. Ström; A. Bjelle; E. Möller

Publisher: Springer
Year: 1985
Tongue: English
Weight: 461 KB
Volume: 4
Category: Article
ISSN: 0770-3198
DOI: 10.1007/bf02032318

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

HLA–D region antigens in patients with r

HLA–D region antigens in patients with rheumatoid arthritis

✍ Christine T. McCusker; Barbara Reid; Donna Green; Dafna D. Gladman; W. Watson Bu 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 640 KB

Association of HLA-Bw35 with mucocutaneo

Association of HLA-Bw35 with mucocutaneous lesions in rheumatoid arthritis patients undergoing sodium aurothiomalate therapy

✍ Hubert G. Nüsslein; Helga Jahn; Georg Lösch; Irene Guggenmoos-Holzmann; Wolfgang 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 305 KB 👁 2 views

Modulation of RANKL and osteoprotegerin

Modulation of RANKL and osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis in response to disease‐modifying antirheumatic drug treatment and correlation with radiologic outcome

✍ Haynes, David ;Crotti, Tania ;Weedon, Helen ;Slavotinek, John ;Au, Virginia ;Col 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 881 KB

Comparison of the response to infliximab

Comparison of the response to infliximab or etanercept monotherapy with the response to cotherapy with methotrexate or another disease-modifying antirheumatic drug in patients with rheumatoid arthritis: Results from the British Society for Rheumatology Biologics Register

✍ Kimme L. Hyrich; Deborah P. M. Symmons; Kath D. Watson; Alan J. Silman; British 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 3 views

## Abstract ## Objective To compare outcome at 6 months in unselected “real‐world” patients with rheumatoid arthritis treated with etanercept or infliximab as either monotherapy, cotherapy with methotrexate (MTX), or cotherapy with another disease‐modifying antirheumatic drug (DMARD). ## Methods